Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002863 · ClinicalTrials.gov registry record · Phase 1
Cryosurgery in Treating Patients With Soft Tissue Sarcoma
A Phase 1 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT00002863: Clinical Trial Phase 1 study, sponsored by University of Southern California.
NCT00002863 is a Phase 1 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 19 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002863, a Phase 1 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
RATIONALE: Cryosurgery kills cancer cells by freezing them. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining cryosurgery with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of cryosurgery with or without chemotherapy in treating patients who have soft tissue sarcoma.
Interventions
- PROCEDURE conventional surgery
- DRUG chemotherapy
- PROCEDURE cryosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 1996-06 |
| Est. Completion | 2000-07 |
| Phase | Phase 1 |
Why NCT00002863 stopped before completion
NCT00002863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 3 interventions - of which conventional surgery is the first listed.
NCT00002863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002863 about?
NCT00002863 is a clinical study titled "Cryosurgery in Treating Patients With Soft Tissue Sarcoma". RATIONALE: Cryosurgery kills cancer cells by freezing them. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining cryosurgery with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of cryosurger...
What is the current status of trial NCT00002863?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 1996-06. Estimated completion is 2000-07.
What interventions are being tested in trial NCT00002863?
The interventions under investigation include: conventional surgery (PROCEDURE), chemotherapy (DRUG), cryosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00002863?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00002863's enrollment target sits among peer trials
19 1716th of 2000 higher than 281 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia